.

follow-on-google-news

The shares of one of the leading pharmaceutical companies, which is a market leader in some of the consumer healthcare products like condoms and pregnancy test kits jumped 2 percent in the day’s trade following a strategic investment of Rs. 10 Crores. 

At 12:13 p.m. the shares of Mankind Pharma Limited were trading at Rs. 1,907.05, up 0.74 percent from its previous day’s close price of Rs. 1,892.95 and its market capitalization is Rs. 76,348 Crores. 

Mankind Pharma Limited has made an investment of GBP 999,900 or Rs. 10.53 Crores in Actimed Therapeutics Limited to acquire a 1.29 percent stake in it thereby increasing its holding stake to 10.19 percent. 

It is a strategic investment in the field of treatment of cancer cachexia, amyotrophic lateral sclerosis, and other muscle wasting disorders. 

Mankind Pharma Limited is one of the leading players in the pharmaceutical industry, it is engaged in developing, manufacturing, and selling a diverse range of markets pharmaceutical formulations across various acute and chronic therapeutic areas and several consumer healthcare products. 

Sales mix representing Diversified Therapy Presence is as follows, 16 percent Anti-Infectives, 13 percent Gastro Intestinal, 11 percent Gastro Intestinal, 9 percent VMN, 8 percent, 8 percent Respiratory, 6 percent Dermatology, 7 percent Gynaecology, 5 percent Urology, 5 percent Pain / Analgesics, 3 percent Neuro / CNS and 9 percent others. 

It is the #1 market leader in manufacturing condoms with a 30 percent market share, pregnancy test kits with an 85 percent market share, medicated anti-acne products with a 34 percent market share and it is one of the leading players in many more in the pharmaceutical segment. 

It has reported a return on equity (ROE) of 19.27 percent and a return on capital employed (ROCE) of 23.49 percent, it is making good returns on its equity and capital employed. 

The company’s revenue from operations grew 12.44 percent from Rs. 7,781.56 Crores in FY22 to Rs. 8,749.43 Crores in FY23, accompanied by profits of Rs. 1,433.48 Crores to Rs. 1,281.86 Crores. 

Written by: Bharath K.S

×